US FDA Approves ZYNTEGLO® (betibeglogene autotemcel)

  • 1 Replies

Offline Bostonian_04

  • ****
  • 395
  • Gender: Male
US FDA Approves ZYNTEGLO® (betibeglogene autotemcel)
« on: August 18, 2022, 02:14:15 PM »

Bluebird bio announced that the U.S. Food and Drug Administration (FDA) has approved ZYNTEGLO® (betibeglogene autotemcel), a one-time gene therapy to treat patients with beta-thalassemia who require regular red blood cell (RBC) transfusions.

You can find a full press release and more information at
Quis custodiet ipsos custodes ? - Plato


Offline Andy Battaglia

  • *****
  • 8764
  • Gender: Male
  • Will thal rule you or will you rule thal?
Re: US FDA Approves ZYNTEGLO® (betibeglogene autotemcel)
« Reply #1 on: September 03, 2022, 08:10:39 PM »
The price tag is enormous. Do you know anything about if insurance companies will help cover the cost?

All we are saying is give thals a chance.


SMF spam blocked by CleanTalk